Save information for later
Sign Up

Learn About Angiosarcoma of the Liver

View Main Condition: Angiosarcoma

What is the definition of Angiosarcoma of the Liver?
A malignant vascular neoplasm arising from the liver.
What are the alternative names for Angiosarcoma of the Liver?
  • Angiosarcoma of the liver
Who are the top Angiosarcoma of the Liver Local Doctors?
Experienced in Angiosarcoma of the Liver
Gastroenterology
Experienced in Angiosarcoma of the Liver
Gastroenterology
8600 Old Georgetown Rd, 
Bethesda, MD 
 (1.2 mi)
Languages Spoken:
English

Theo Heller is a Gastroenterologist in Bethesda, Maryland. Dr. Heller and is rated as an Experienced provider by MediFind in the treatment of Angiosarcoma of the Liver. His top areas of expertise are Hepatitis D, Hepatitis, Portal Hypertension, Gastrectomy, and Endoscopy.

Experienced in Angiosarcoma of the Liver
Internal Medicine
Experienced in Angiosarcoma of the Liver
Internal Medicine
10 Center Dr, Crc Bldg-10, Rm. 4-5722, 
Bethesda, MD 
 (1.4 mi)
Languages Spoken:
English

Christopher Koh is an Internal Medicine provider in Bethesda, Maryland. Dr. Koh and is rated as an Experienced provider by MediFind in the treatment of Angiosarcoma of the Liver. His top areas of expertise are Hepatitis D, Hepatitis, Portal Hypertension, Endoscopy, and Colonoscopy.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Angiosarcoma of the Liver
Gastroenterology
Advanced in Angiosarcoma of the Liver
Gastroenterology

Medical Faculty Associates, Inc

2150 Pennsylvania Ave Nw, 
Washington, DC 
 (6.3 mi)
Experience:
12+ years
Languages Spoken:
English

Samuel Schueler is a Gastroenterologist in Washington, Washington, D.c.. Dr. Schueler has been practicing medicine for over 12 years and is rated as an Advanced provider by MediFind in the treatment of Angiosarcoma of the Liver. His top areas of expertise are Familial Colorectal Cancer, Angiosarcoma of the Liver, Gastrointestinal Bleeding, Endoscopy, and Colonoscopy.

What are the latest Angiosarcoma of the Liver Clinical Trials?
A Phase 1, Open-Label, Dose-Escalation and Expansion Study of AGX101, a TM4SF1 Directed Antibody Drug Conjugate in Patients with Unresectable, Locally Advanced, or Metastatic Solid Tumors

Summary: AGX101 is an antibody-drug conjugate (ADC) therapy for tumor-forming cancers. The purpose of this study is to learn about AGX101 effects and safety at various dose levels in an all-comers advanced solid cancer patient population. AGX101will be administered intravenously. Dosing of AGX101 will be repeated once every 3, 6 or 9 weeks. Participants may continue study treatment until disease progressio...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers

Summary: The aim of this French multicenter retrospective study is to describ rare primary hepatic cancers clinical, histological and radiological features, to obtain a biological tumor and blood collection, and to evaluate the efficacy of treatments received in clinical practice in order to determine optimal therapeutic sequences. This retrospective cohort will be the backbone of future translational stud...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Angiosarcoma of the Liver?